AVIR
Atea Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$5.86
+0.60%Leverage
- Debt / equity
- 0.00x
- Net debt / equity
- -0.37x
- Debt / assets
- 0.00x
- Debt / EBITDA
- -0.00x
- Net debt / EBITDA
- 0.44x
Liquidity & coverage
- Current ratio
- 8.13x
- Quick ratio
- 8.13x
- Cash ratio
- 7.80x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- $200.5M
Cash & dividend
- FCF / debt
- -358.66x
- Cash flow / debt
- -358.66x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026